Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Tóm tắt
Từ khóa
Tài liệu tham khảo
Speiser, 2010, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 95, 4133, 10.1210/jc.2009-2631
Gruñieiro-Papendieck, 2008, Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina, J Pediatr Endocrinol Metab, 21, 73
Shetty, 2012, Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period, J Paediatr Child Health, 48, 1029, 10.1111/j.1440-1754.2012.02584.x
Gleeson, 2008, Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia, J Paediatr Child Health, 44, 554, 10.1111/j.1440-1754.2008.01383.x
Nascimento, 2014, Ten-year evaluation of a neonatal screening program for congenital adrenal hyperplasia, Arq Bras Endocrinol Metabol, 58, 765, 10.1590/0004-2730000003310
Silveira, 2009, Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia, Clin Genet, 76, 503, 10.1111/j.1399-0004.2009.01274.x
Pezzuti, 2014, A three-year follow-up of congenital adrenal hyperplasia newborn screening, J Pediatr (Rio J), 90, 300, 10.1016/j.jped.2013.09.007
Kopacek, 2017, Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants, BMC Pediatr, 17, 22, 10.1186/s12887-016-0772-x
Zhong, 2016, The status of neonatal screening in China, 2013, J Med Screen, 23, 59, 10.1177/0969141315597715
Dumic, 2009, Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006, Horm Res, 72, 310, 10.1159/000245933
González, 2013, Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience, Clin Chim Acta, 421, 73, 10.1016/j.cca.2013.02.020
Votava, 2012, Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance, Eur J Pediatr, 171, 935, 10.1007/s00431-011-1656-6
Coulm, 2012, Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003, Arch Pediatr Adolesc Med, 166, 113, 10.1001/archpediatrics.2011.774
Odenwald, 2015, Classic congenital adrenal hyperplasia due to 21-hydroxylase-deficiency: 13 years of neonatal screening and follow-up in Bavaria, Klin Padiatr, 227, 278, 10.1055/s-0035-1554639
Kaur, 2016, Current and future perspective of newborn screening: an Indian scenario, J Pediatr Endocrinol Metab, 29, 5, 10.1515/jpem-2015-0009
Morikawa, 2014, Results from 28 years of newborn screening for congenital adrenal hyperplasia in Sapporo, Clin Pediatr Endocrinol, 23, 35, 10.1297/cpe.23.35
Tsuji, 2015, Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study, BMC Pediatr, 15, 209, 10.1186/s12887-015-0529-y
Heather, 2015, Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994–2013, J Clin Endocrinol Metab, 100, 1002, 10.1210/jc.2014-3168
Gidlöf, 2014, Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study, JAMA Pediatr, 168, 567, 10.1001/jamapediatrics.2013.5321
Khalid, 2012, Incidence and clinical features of congenital adrenal hyperplasia in Great Britain, Arch Dis Child, 97, 101, 10.1136/archdischild-2011-300234
Al Hosani, 2014, Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011, East Mediterr Health J, 20, 17, 10.26719/2014.20.1.17
Larrandaburu, 2015, Ethics, genetics and public policies in Uruguay: newborn and infant screening as a paradigm, J Community Genet, 6, 241, 10.1007/s12687-015-0236-2
van der Kamp, 2004, Neonatal screening for congenital adrenal hyperplasia, Eur J Endocrinol, 151, U71, 10.1530/eje.0.151u071
White, 1984, HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation, Proc Natl Acad Sci USA, 81, 7505, 10.1073/pnas.81.23.7505
Krone, 2007, Congenital adrenal hyperplasia and P450 oxidoreductase deficiency, Clin Endocrinol (Oxf), 66, 162, 10.1111/j.1365-2265.2006.02740.x
Kamrath, 2012, Increased activation of the alternative “backdoor” pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis, J Clin Endocrinol Metab, 97, E367, 10.1210/jc.2011-1997
White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Endocr Rev, 21, 245
National Newborn Screening and Global Resource Center. Newborn Screening Reports and Publications. Incidence reports: 2006. Available at: genes-r-us.uthscsa.edu/newborn_reports. Accessed 28 August 2017.
Kohn, 1982, Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia, J Clin Endocrinol Metab, 55, 817, 10.1210/jcem-55-5-817
Speiser, 1986, High frequency of nonclassical steroid 21-hydroxylase deficiency, Obstet Gynecol Surv, 41, 244, 10.1097/00006254-198604000-00017
Hannah-Shmouni, 2017, Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians, Genet Med, 19, 1276, 10.1038/gim.2017.46
Yang, 1999, Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations, J Biol Chem, 274, 12147, 10.1074/jbc.274.17.12147
The Human Gene Mutation Database. Available at: www.hgmd.cf.ac.uk/ac/index.php. Accessed July 27, 2018.
Krone, 2000, Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany, J Clin Endocrinol Metab, 85, 1059, 10.1210/jcem.85.3.6441
Speiser, 1992, Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Invest, 90, 584, 10.1172/JCI115897
Simonetti, 2018, CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants, Hum Mutat, 39, 5, 10.1002/humu.23351
Miller WL , Merke DP. Tenascin-X, congenital adrenal hyperplasia and the CAH-X syndrome. Horm Res Paediatr. 2018;89(5):352–361.
Tusie-Luna, 1990, Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus, J Biol Chem, 265, 20916, 10.1016/S0021-9258(17)45304-X
Blanché, 1997, Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women, Hum Genet, 101, 56, 10.1007/s004390050586
Deneux, 2001, Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 86, 207, 10.1210/jcem.86.1.7131
Tamhane SU, Rodriguez-Gutierrez R, Iqbal AM, Prokop L, Bancos I, Speiser PW, Murad MH. Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2018;103(11):4097–4103.
Almasri J, Zaiem F, Rodriguez-Gutierrez R, Tamhane SU, Iqbal AM, Prokop LJ, Speiser PW, Baskin LS, Bancos I, Murad MH. Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2018;103(11):4089–4096.
Pang, 1997, Current status of neonatal screening for congenital adrenal hyperplasia, Curr Opin Pediatr, 9, 419, 10.1097/00008480-199708000-00018
Therrell, 2001, Newborn screening for congenital adrenal hyperplasia, Endocrinol Metab Clin North Am, 30, 15, 10.1016/S0889-8529(08)70017-3
Balsamo, 1996, Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980–1995, Pediatrics, 98, 362
Brosnan, 1999, Effect of newborn screening for congenital adrenal hyperplasia, Arch Pediatr Adolesc Med, 153, 1272, 10.1001/archpedi.153.12.1272
Therrell, 1998, Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia, Pediatrics, 101, 583, 10.1542/peds.101.4.583
Thilén, 1998, Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden, Pediatrics, 101, E11, 10.1542/peds.101.4.e11
Strnadová, 2007, Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria, Eur J Pediatr, 166, 1, 10.1007/s00431-006-0154-8
Hird, 2014, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening, Arch Dis Child, 99, 158, 10.1136/archdischild-2013-304473
Lebovitz, 1984, Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening, Am J Dis Child, 138, 571, 10.1001/archpedi.1984.02140440055014
Nordenström, 2005, Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening, Horm Res, 63, 22
Thompson, 1989, Screening for congenital adrenal hyperplasia: distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens, J Pediatr, 114, 400, 10.1016/S0022-3476(89)80557-8
Gidlöf, 2013, One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study, Lancet Diabetes Endocrinol, 1, 35, 10.1016/S2213-8587(13)70007-X
Watson, 2006, Newborn screening: toward a uniform screening panel and system [Main report], Genet Med, 8, 12S, 10.1097/01.gim.0000223467.60151.02
Grosse, 2007, How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia, Horm Res, 67, 284
Van der Kamp, 2001, Newborn screening for congenital adrenal hyperplasia in the Netherlands, Pediatrics, 108, 1320, 10.1542/peds.108.6.1320
Nass, 1991, Learning disabilities in children with congenital adrenal hyperplasia, J Child Neurol, 6, 306, 10.1177/088307389100600404
Carroll, 2006, Comprehensive cost-utility analysis of newborn screening strategies, Pediatrics, 117, S287, 10.1542/peds.2005-2633H
Yoo, 2009, The cost effectiveness of screening newborns for congenital adrenal hyperplasia, Public Health Genomics, 12, 67, 10.1159/000156115
Chan, 2013, Congenital adrenal hyperplasia and the second newborn screen, J Pediatr, 109
Gonzalez, 1990, Direct solid-phase time-resolved fluoroimmunoassay of 17α-hydroxyprogesterone in serum and dried blood spots on filter paper, Clin Chem, 36, 1667, 10.1093/clinchem/36.9.1667
Pang, 1977, Microfilter paper method for 17α-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia, J Clin Endocrinol Metab, 45, 1003, 10.1210/jcem-45-5-1003
Varness, 2005, Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls, J Pediatr, 147, 493, 10.1016/j.jpeds.2005.04.035
Allen, 1997, Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels, J Pediatr, 130, 128, 10.1016/S0022-3476(97)70321-4
Olgemöller, 2003, Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value, J Clin Endocrinol Metab, 88, 5790, 10.1210/jc.2002-021732
Sarafoglou, 2014, Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants, J Pediatr, 164, 1136, 10.1016/j.jpeds.2014.01.038
Sarafoglou, 2012, Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia, Pediatrics, 130, e1261, 10.1542/peds.2012-1219
Hayashi, 2017, Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening, Clin Endocrinol (Oxf), 86, 480, 10.1111/cen.13292
Held, 2015, Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states, Mol Genet Metab, 116, 133, 10.1016/j.ymgme.2015.08.004
van der Kamp, 2005, Cutoff levels of 17-α-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight, J Clin Endocrinol Metab, 90, 3904, 10.1210/jc.2004-2136
Nomura, 1997, Immature adrenal steroidogenesis in preterm infants, Early Hum Dev, 49, 225, 10.1016/S0378-3782(97)00037-6
Wong, 1992, Identification of the steroids in neonatal plasma that interfere with 17 α-hydroxyprogesterone radioimmunoassays, Clin Chem, 38, 1830, 10.1093/clinchem/38.9.1830
al Saedi, 1995, Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants, J Pediatr, 126, 985, 10.1016/S0022-3476(95)70229-6
Gatelais, 2004, Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia, Pediatr Res, 56, 701, 10.1203/01.PDR.0000142733.50918.6E
King, 2001, Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia, Arch Pediatr Adolesc Med, 155, 1038, 10.1001/archpedi.155.9.1038
White, 2009, Neonatal screening for congenital adrenal hyperplasia, Nat Rev Endocrinol, 5, 490, 10.1038/nrendo.2009.148
Lacey, 2004, Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry, Clin Chem, 50, 621, 10.1373/clinchem.2003.027193
Rauh, 2006, Automated, fast and sensitive quantification of 17α-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction, Steroids, 71, 450, 10.1016/j.steroids.2006.01.015
Janzen, 2007, Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry, J Clin Endocrinol Metab, 92, 2581, 10.1210/jc.2006-2890
Minutti, 2004, Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia, J Clin Endocrinol Metab, 89, 3687, 10.1210/jc.2003-032235
Matern, 2007, Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007), J Inherit Metab Dis, 30, 585, 10.1007/s10545-007-0691-y
Schwarz, 2009, Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience, Pediatr Res, 66, 230, 10.1203/PDR.0b013e3181aa3777
Seo, 2014, Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation, J Perinat Med, 42, 121, 10.1515/jpm-2013-0154
De Jesús, 2010, Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening, Clin Chim Acta, 411, 1684, 10.1016/j.cca.2010.06.029
Kamrath, 2016, Diagnosis of 21-hydroxylase deficiency by urinary metabolite ratios using gas chromatography–mass spectrometry analysis: reference values for neonates and infants, J Steroid Biochem Mol Biol, 156, 10, 10.1016/j.jsbmb.2015.10.013
Yang, 2001, Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, Mol Diagn, 6, 193, 10.2165/00066982-200106030-00007
Fitness, 1999, Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia, J Clin Endocrinol Metab, 84, 960
Sørensen, 2008, Multiplex ligation-dependent probe amplification technique for copy number analysis on small amounts of DNA material, Anal Chem, 80, 9363, 10.1021/ac801688c
Kösel, 2005, Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency, Clin Chem, 51, 298, 10.1373/clinchem.2004.042416
Olney, 2002, Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population, J Clin Endocrinol Metab, 87, 735, 10.1210/jcem.87.2.8273
Nordenström, 1999, Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency, J Clin Endocrinol Metab, 84, 1505
Riepe, 2002, Management of congenital adrenal hyperplasia: results of the ESPE questionnaire, Horm Res, 58, 196
Németh, 2012, Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone, Clin Chim Acta, 414, 211, 10.1016/j.cca.2012.09.013
Meyer-Bahlburg, 2017, Syndrome-related stigma in the general social environment as reported by women with classical congenital adrenal hyperplasia, Arch Sex Behav, 46, 341, 10.1007/s10508-016-0862-8
Hill, 2011, Non-invasive prenatal determination of fetal sex: translating research into clinical practice, Clin Genet, 80, 68, 10.1111/j.1399-0004.2010.01533.x
Tardy-Guidollet, 2014, New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002–2011), J Clin Endocrinol Metab, 99, 1180, 10.1210/jc.2013-2895
Eunice, 2013, Prenatal treatment of mothers with fetuses at risk for congenital adrenal hyperplasia: how relevant is it to Indian context, Indian J Endocrinol Metab, 17, 373, 10.4103/2230-8210.111596
New, 2014, Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma, J Clin Endocrinol Metab, 99, E1022, 10.1210/jc.2014-1118
Goto, 2006, In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development, J Clin Invest, 116, 953, 10.1172/JCI25091
Kari, 1996, Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy, Pediatr Res, 40, 319, 10.1203/00006450-199608000-00021
Miller, 2013, Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits, Am J Obstet Gynecol, 208, 354, 10.1016/j.ajog.2012.10.885
Mercè Fernández-Balsells, 2010, Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses, Clin Endocrinol (Oxf), 73, 436, 10.1111/j.1365-2265.2010.03826.x
New, 2012, An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia, Semin Reprod Med, 30, 396, 10.1055/s-0032-1324723
Gorduza, 2014, Late prenatal dexamethasone and phenotype variations in 46,XX CAH: concerns about current protocols and benefits for surgical procedures, J Pediatr Urol, 10, 941, 10.1016/j.jpurol.2014.02.003
Food and Drug Administration, Health and Human Services. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Fed Regist. 2014;79(233):72063–72103.
Carmichael, 2007, National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts, Am J Obstet Gynecol, e1
Rijk, 2017, Prenatal Treatment with dexamethasone in suspected congenital adrenal hyperplasia and orofacial cleft: a case report and review of the literature, Pediatr Endocrinol Rev, 15, 21
Grunt, 2013, Acute encephalopathy with unilateral cortical-subcortical lesions in two unrelated kindreds treated with glucocorticoids prenatally for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: established facts and novel insight, Horm Res Paediatr, 80, 57, 10.1159/000348515
Drake, 2010, Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet, Endocrinology, 151, 1581, 10.1210/en.2009-1088
Manojlović-Stojanoski, 2014, Morpho-functional characteristics of rat fetal thyroid gland are affected by prenatal dexamethasone exposure, Steroids, 84, 22, 10.1016/j.steroids.2014.03.006
Poulain, 2012, Dexamethasone induces germ cell apoptosis in the human fetal ovary, J Clin Endocrinol Metab, 97, E1890, 10.1210/jc.2012-1681
Wapner, 2007, Long-term outcomes after repeat doses of antenatal corticosteroids, N Engl J Med, 357, 1190, 10.1056/NEJMoa071453
Murphy, 2008, Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial, Lancet, 372, 2143, 10.1016/S0140-6736(08)61929-7
Davis, 2009, Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation, J Perinatol, 29, 731, 10.1038/jp.2009.85
Braun, 2013, Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk, Endocr Rev, 34, 885, 10.1210/er.2013-1012
New, 2001, Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies, J Clin Endocrinol Metab, 86, 5651, 10.1210/jcem.86.12.8072
Harris, 2011, Glucocorticoids, prenatal stress and the programming of disease, Horm Behav, 59, 279, 10.1016/j.yhbeh.2010.06.007
Kelly, 2012, Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism, Pediatrics, 129, e1282, 10.1542/peds.2011-3175
Nugent, 2013, Chronic glucocorticoid exposure potentiates placental chorionic plate artery constriction: implications for aberrant fetoplacental vascular resistance in fetal growth restriction, Endocrinology, 154, 876, 10.1210/en.2012-1927
Seckl, 1997, How safe is long-term prenatal glucocorticoid treatment, JAMA, 277, 1077, 10.1001/jama.1997.03540370067039
Moisiadis, 2014, Glucocorticoids and fetal programming part 1: outcomes, Nat Rev Endocrinol, 10, 391, 10.1038/nrendo.2014.73
Seckl, 2004, Prenatal glucocorticoids and long-term programming, Eur J Endocrinol, 151, U49, 10.1530/eje.0.151u049
Damsted, 2011, Exogenous glucocorticoids and adverse cerebral effects in children, Eur J Paediatr Neurol, 15, 465, 10.1016/j.ejpn.2011.05.002
Andela, 2015, mechanisms in endocrinology: Cushing’s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies, Eur J Endocrinol, 173, R1, 10.1530/EJE-14-1101
Peffer, 2015, Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain, Mol Endocrinol, 29, 658, 10.1210/me.2015-1042
Heberden, 2013, Dexamethasone inhibits the maturation of newly formed neurons and glia supplemented with polyunsaturated fatty acids, J Steroid Biochem Mol Biol, 138, 395, 10.1016/j.jsbmb.2013.07.010
Crudo, 2013, Effects of antenatal synthetic glucocorticoid on glucocorticoid receptor binding, DNA methylation, and genome-wide mRNA levels in the fetal male hippocampus, Endocrinology, 154, 4170, 10.1210/en.2013-1484
Crudo, 2013, Glucocorticoid programming of the fetal male hippocampal epigenome, Endocrinology, 154, 1168, 10.1210/en.2012-1980
Crudo, 2012, Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects, Endocrinology, 153, 3269, 10.1210/en.2011-2160
Samarasinghe, 2011, Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation, Proc Natl Acad Sci USA, 108, 16657, 10.1073/pnas.1102821108
Hirvikoski, 2007, Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone, J Clin Endocrinol Metab, 92, 542, 10.1210/jc.2006-1340
Hirvikoski, 2008, Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems, Eur J Endocrinol, 159, 309, 10.1530/EJE-08-0280
Hirvikoski, 2011, Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia—a pilot study, Acta Paediatr, 100, e112, 10.1111/j.1651-2227.2011.02260.x
Wallensteen, 2016, Sex-dimorphic effects of prenatal treatment with dexamethasone, J Clin Endocrinol Metab, 101, 3838, 10.1210/jc.2016-1543
Browne, 2015, Working memory performance is reduced in children with congenital adrenal hyperplasia, Horm Behav, 67, 83, 10.1016/j.yhbeh.2014.11.014
Collaer, 2016, Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance, Psychoneuroendocrinology, 64, 164, 10.1016/j.psyneuen.2015.11.010
Meyer-Bahlburg, 2012, Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Eur J Endocrinol, 167, 103, 10.1530/EJE-11-0789
Maryniak, 2014, Cognitive and social function in girls with congenital adrenal hyperplasia—influence of prenatally administered dexamethasone, Child Neuropsychol, 20, 60, 10.1080/09297049.2012.745495
Bergman, 2010, Maternal prenatal cortisol and infant cognitive development: moderation by infant–mother attachment, Biol Psychiatry, 67, 1026, 10.1016/j.biopsych.2010.01.002
Reynolds, 2012, Antenatal glucocorticoid treatment: are we doing harm to term babies, J Clin Endocrinol Metab, 97, 3457, 10.1210/jc.2012-3201
Alexander, 2012, Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children, J Clin Endocrinol Metab, 97, 3538, 10.1210/jc.2012-1970
Khalife, 2013, Prenatal glucocorticoid treatment and later mental health in children and adolescents, PLoS One, 8, e81394, 10.1371/journal.pone.0081394
Resmini, 2012, Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing’s syndrome, J Clin Endocrinol Metab, 97, 663, 10.1210/jc.2011-2231
Santos, 2014, Small cerebellar cortex volume in patients with active Cushing’s syndrome, Eur J Endocrinol, 171, 461, 10.1530/EJE-14-0371
Ragnarsson, 2012, Long-term cognitive impairments and attentional deficits in patients with Cushing’s disease and cortisol-producing adrenal adenoma in remission, J Clin Endocrinol Metab, 97, E1640, 10.1210/jc.2012-1945
Wagenmakers, 2012, Impaired quality of life in patients in long-term remission of Cushing’s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism, Eur J Endocrinol, 167, 687, 10.1530/EJE-12-0308
Tiemensma, 2010, Subtle cognitive impairments in patients with long-term cure of Cushing’s disease, J Clin Endocrinol Metab, 95, 2699, 10.1210/jc.2009-2032
Tiemensma, 2010, Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease, J Clin Endocrinol Metab, 95, E129, 10.1210/jc.2010-0512
Webb, 2018, Quantitative brain MRI in congenital adrenal hyperplasia: in vivo assessment of the cognitive and structural impact of steroid hormones, J Clin Endocrinol Metab, 103, 1330, 10.1210/jc.2017-01481
Pole, 2009, Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma, J Asthma, 46, 47, 10.1080/02770900802262795
Tseng, 2016, Antenatal dexamethasone exposure in preterm infants is associated with allergic diseases and the mental development index in children, Int J Environ Res Public Health, 13, E1206, 10.3390/ijerph13121206
Sun, 2016, Prenatal dexamethasone exposure increases the susceptibility to autoimmunity in offspring rats by epigenetic programing of glucocorticoid receptor, BioMed Res Int, 2016, 9409452, 10.1155/2016/9409452
Chou, 2017, Age-dependent effects of prenatal dexamethasone exposure on immune responses in male rats, Tohoku J Exp Med, 241, 225, 10.1620/tjem.241.225
Dalziel, 2005, Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial, Lancet, 365, 1856, 10.1016/S0140-6736(05)66617-2
Iqbal, 2012, Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function, Endocrinology, 153, 3295, 10.1210/en.2012-1054
Quinn, 2014, Adrenal steroidogenesis following prenatal dexamethasone exposure in the spiny mouse, J Endocrinol, 221, 347, 10.1530/JOE-13-0514
Hirvikoski, 2012, Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint, J Clin Endocrinol Metab, 97, 1881, 10.1210/jc.2012-1222
Dörr, 2015, Experts’ opinion on the prenatal therapy of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency—guideline of DGKED in cooperation with DGGG (S1-level, AWMF registry no. 174/013, July 2015), Geburtshilfe Frauenheilkd, 75, 1232, 10.1055/s-0041-109717
Sparrow, 2013, Gender eugenics? The ethics of PGD for intersex conditions, Am J Bioeth, 13, 29, 10.1080/15265161.2013.828115
Simpson, 2017, Preimplantation diagnosis and other modern methods for prenatal diagnosis, J Steroid Biochem Mol Biol, 165, 124, 10.1016/j.jsbmb.2016.03.022
Soto-Lafontaine, 2018, Dealing with treatment and transfer requests: how PGD-professionals discuss ethical challenges arising in everyday practice, Med Health Care Philos, 21, 375, 10.1007/s11019-017-9811-0
Ray, 2015, Performance enhancement in the measurement of 5 endogenous steroids by LC-MS/MS combined with differential ion mobility spectrometry, Clin Chim Acta, 438, 330, 10.1016/j.cca.2014.07.036
Janzen, 2012, Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing, Horm Res Paediatr, 77, 195, 10.1159/000337974
New, 1983, Genotyping steroid 21-hydroxylase deficiency: hormonal reference data, J Clin Endocrinol Metab, 57, 320, 10.1210/jcem-57-2-320
Abdu, 1999, Comparison of the low dose short synacthen test (1 μg), the conventional dose short synacthen test (250 μg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease, J Clin Endocrinol Metab, 84, 838
Caulfield, 2002, The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens, J Clin Endocrinol Metab, 87, 3682, 10.1210/jcem.87.8.8712
Azziz, 1999, Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study, Fertil Steril, 72, 915, 10.1016/S0015-0282(99)00383-0
Armengaud, 2009, Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche, J Clin Endocrinol Metab, 94, 2835, 10.1210/jc.2009-0314
Bidet, 2009, Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members, J Clin Endocrinol Metab, 94, 1570, 10.1210/jc.2008-1582
Török, 2003, Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency, Exp Clin Endocrinol Diabetes, 111, 27, 10.1055/s-2003-37497
Speiser, 1998, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency, Clin Endocrinol (Oxf), 49, 411, 10.1046/j.1365-2265.1998.00559.x
Wedell, 1994, Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation, J Clin Endocrinol Metab, 78, 1145
Wilson, 1995, Steroid 21-hydroxylase deficiency: genotype may not predict phenotype, J Clin Endocrinol Metab, 80, 2322
Bachega, 2000, Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Clin Endocrinol (Oxf), 52, 601, 10.1046/j.1365-2265.2000.00995.x
Costa-Barbosa, 2011, Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers, J Endocrinol Invest, 34, 587
Balsamo, 2000, CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia–Romagna region, Clin Endocrinol (Oxf), 53, 117, 10.1046/j.1365-2265.2000.01048.x
Wedell, 1992, Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations, Proc Natl Acad Sci USA, 89, 7232, 10.1073/pnas.89.15.7232
Fiet, 1988, Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia, J Clin Endocrinol Metab, 66, 659, 10.1210/jcem-66-4-659
Peter, 1990, Improved test to identify heterozygotes for congenital adrenal hyperplasia without index case examination, Lancet, 335, 1296, 10.1016/0140-6736(90)91185-D
Mullis, 1990, Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency, Eur J Pediatr, 150, 22, 10.1007/BF01959473
Bonfig, 2018, Sodium chloride supplementation is not routinely performed in the majority of German and Austrian infants with classic salt-wasting congenital adrenal hyperplasia and has no effect on linear growth and hydrocortisone or fludrocortisone dose, Horm Res Paediatr, 89, 7, 10.1159/000481775
Nimkarn, 2007, Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia, J Clin Endocrinol Metab, 92, 137, 10.1210/jc.2006-0964
Frisch, 2001, Salt wasting in simple virilizing congenital adrenal hyperplasia, J Pediatr Endocrinol Metab, 14, 1649, 10.1515/JPEM.2001.14.9.1649
Muthusamy, 2010, Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis, J Clin Endocrinol Metab, 95, 4161, 10.1210/jc.2009-2616
Bonfig, 2007, Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty, J Clin Endocrinol Metab, 92, 1635, 10.1210/jc.2006-2109
Punthakee, 2003, Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency, J Pediatr, 143, 402, 10.1067/S0022-3476(03)00294-4
Rivkees, 2000, Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth, Pediatrics, 106, 767, 10.1542/peds.106.4.767
Sarafoglou, 2015, Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets, J Clin Pharmacol, 55, 452, 10.1002/jcph.424
Merke, 2001, Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 86, 441, 10.1210/jcem.86.1.7275
Neumann, 2017, Quality of compounded hydrocortisone capsules used in the treatment of children, Eur J Endocrinol, 177, 239, 10.1530/EJE-17-0248
Barillas, 2018, Iatrogenic Cushing syndrome in a child with congenital adrenal hyperplasia: erroneous compounding of hydrocortisone, J Clin Endocrinol Metab, 103, 7, 10.1210/jc.2017-01595
German, 2008, Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy, J Clin Endocrinol Metab, 93, 4707, 10.1210/jc.2008-0519
Balsamo, 2003, CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency, J Clin Endocrinol Metab, 88, 5680, 10.1210/jc.2003-030123
Bonfig, 2009, Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation, J Clin Endocrinol Metab, 94, 3882, 10.1210/jc.2009-0942
Grigorescu-Sido, 2003, Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome, Horm Res, 60, 84
Van der Kamp, 2002, Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients, Arch Dis Child, 87, 139, 10.1136/adc.87.2.139
Hindmarsh, 2015, Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations, Clin Endocrinol (Oxf), 82, 557, 10.1111/cen.12653
Charmandari, 2001, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty, J Clin Endocrinol Metab, 86, 2701, 10.1210/jcem.86.6.7522
Arlt, 2010, Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients, J Clin Endocrinol Metab, 95, 5110, 10.1210/jc.2010-0917
Finkielstain, 2012, Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 97, 4429, 10.1210/jc.2012-2102
Martinerie, 2009, Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates, Endocrinology, 150, 4414, 10.1210/en.2008-1498
De Leo, 2007, Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome, Fertil Steril, 88, 113, 10.1016/j.fertnstert.2006.11.137
de Nadai, 2015, Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial, Blood Press Monit, 20, 310, 10.1097/MBP.0000000000000139
Martin, 2018, Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 103, 1233, 10.1210/jc.2018-00241
El-Maouche, 2018, Longitudinal assessment of illnesses, stress dosing and illness sequelae in patients with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 103, 2336, 10.1210/jc.2018-00208
Taylor, 2013, Cortisol response to operative stress with anesthesia in healthy children, J Clin Endocrinol Metab, 98, 3687, 10.1210/jc.2013-2148
Reisch, 2012, Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency, Eur J Endocrinol, 167, 35, 10.1530/EJE-12-0161
Odenwald, 2016, Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life, Eur J Endocrinol, 174, 177, 10.1530/EJE-15-0775
Arriza, 1987, Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor, Science, 237, 268, 10.1126/science.3037703
Weise, 2004, Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise, J Clin Endocrinol Metab, 89, 3679, 10.1210/jc.2003-032051
Falhammar, 2014, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 99, E2715, 10.1210/jc.2014-2957
Bornstein, 2016, Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 101, 364, 10.1210/jc.2015-1710
Bonfig, 2014, Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age, Clin Endocrinol (Oxf), 81, 871, 10.1111/cen.12498
Bonfig, 2016, Blood pressure in a large cohort of children and adolescents with classic adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, Am J Hypertens, 29, 266, 10.1093/ajh/hpv087
Turcu, 2016, Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency, Eur J Endocrinol, 174, 601, 10.1530/EJE-15-1181
Turcu, 2017, 11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency, J Clin Endocrinol Metab, 102, 2701, 10.1210/jc.2016-3989
de Groot, 2015, Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia, Clin Chem Lab Med, 53, 461, 10.1515/cclm-2014-0375
Bode, 1999, Home monitoring of 17 hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples, J Pediatr, 134, 185, 10.1016/S0022-3476(99)70413-0
Wieacker, 2015, Therapy monitoring in congenital adrenal hyperplasia by dried blood samples, J Pediatr Endocrinol Metab, 28, 867, 10.1515/jpem-2014-0303
Debono, 2015, Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers, Eur J Endocrinol, 173, 727, 10.1530/EJE-15-0064
Claahsen-van der Grinten, 2014, Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia, Horm Res Paediatr, 82, 238, 10.1159/000365570
Casteràs, 2009, Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate, Clin Endocrinol (Oxf), 70, 833, 10.1111/j.1365-2265.2009.03563.x
King, 2016, Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency, Clin Endocrinol (Oxf), 84, 830, 10.1111/cen.13001
Claahsen-van der Grinten, 2007, Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients, J Clin Endocrinol Metab, 92, 612, 10.1210/jc.2006-1311
Auchus, 2013, Approach to the patient: the adult with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 98, 2645, 10.1210/jc.2013-1440
Reisch, 2013, Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency, J Clin Endocrinol Metab, 98, E1820, 10.1210/jc.2012-3181
Falhammar, 2015, Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome, Endocrine, 50, 32, 10.1007/s12020-015-0656-0
Trapp, 2012, Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update, Steroids, 77, 342, 10.1016/j.steroids.2011.12.009
Spritzer, 1990, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia, J Clin Endocrinol Metab, 70, 642, 10.1210/jcem-70-3-642
Matthews, 2013, What is the best approach to the teenage patient presenting with nonclassical congenital adrenal hyperplasia: should we always treat with glucocorticoids, Clin Endocrinol (Oxf), 78, 338, 10.1111/cen.12065
Moran, 2006, Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia, J Clin Endocrinol Metab, 91, 3451, 10.1210/jc.2006-0062
Bidet, 2010, Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 95, 1182, 10.1210/jc.2009-1383
Eyal, 2017, Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome, Clin Endocrinol (Oxf), 87, 552, 10.1111/cen.13429
Falhammar, 2012, Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia, Eur J Endocrinol, 166, 441, 10.1530/EJE-11-0828
Nandagopal, 2011, Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families, Eur J Endocrinol, 164, 977, 10.1530/EJE-11-0019
Stoupa, 2015, Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule, Horm Res Paediatr, 83, 262, 10.1159/000369901
Raverot, 2016, Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® cortisol II assay, Ann Endocrinol (Paris), 77, 620, 10.1016/j.ando.2016.05.002
Conway, 2007, Congenital adrenal hyperplasia: adolescence and transition, Horm Res, 68, 155
Hughes, 2004, Congenital adrenal hyperplasia: transitional care, Growth Horm IGF Res, 14, S60, 10.1016/j.ghir.2004.03.015
Kruse, 2004, Congenital adrenal hyperplasia—how to improve the transition from adolescence to adult life, Exp Clin Endocrinol Diabetes, 112, 343, 10.1055/s-2004-821013
Jenkins-Jones, 2018, Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia, Eur J Endocrinol, 178, 309, 10.1530/EJE-17-0895
Finkielstain, 2011, Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 96, E161, 10.1210/jc.2010-0319
Falhammar, 2017, Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency: a Swedish population-based national cohort study, J Clin Endocrinol Metab, 102, 4191, 10.1210/jc.2017-01139
Reisch, 2009, High prevalence of reduced fecundity in men with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 94, 1665, 10.1210/jc.2008-1414
Jääskeläinen, 2000, Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency, J Endocrinol Invest, 23, 23, 10.1007/BF03343671
Stikkelbroeck, 2001, High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 86, 5721, 10.1210/jcem.86.12.8090
Martinez-Aguayo, 2007, Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia, J Clin Endocrinol Metab, 92, 4583, 10.1210/jc.2007-0383
Stikkelbroeck, 2004, Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years, J Pediatr Endocrinol Metab, 17, 645, 10.1515/JPEM.2004.17.4.645
Bouvattier, 2015, Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French national survey, J Clin Endocrinol Metab, 100, 2303, 10.1210/jc.2014-4124
Cabrera, 2001, Long term outcome in adult males with classic congenital adrenal hyperplasia, J Clin Endocrinol Metab, 86, 3070
Jääskeläinen, 2000, Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life, Acta Paediatr, 89, 183, 10.1111/j.1651-2227.2000.tb01213.x
Kavoussi, 2016, Sperm retrieval and concomitant tumor resection in azoospermic men with congenital adrenal hyperplasia and bilateral testicular adrenal rest tumors: a case report, J Assist Reprod Genet, 33, 545, 10.1007/s10815-016-0665-9
Hagenfeldt, 2008, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Hum Reprod, 23, 1607, 10.1093/humrep/den118
Chen, 2017, Ovarian adrenal rest tumors undetected by imaging studies and identified at surgery in three females with congenital adrenal hyperplasia unresponsive to increased hormone therapy dosage, Endocr Pathol, 28, 146, 10.1007/s12022-016-9461-4
Lo, 1999, Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 84, 930
Falhammar, 2007, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 92, 110, 10.1210/jc.2006-1350
Girgis, 1997, The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 82, 3926, 10.1210/jcem.82.12.4320
Gussinyé, 1997, Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia, Pediatrics, 100, 671, 10.1542/peds.100.4.671
Mora, 1996, Bone density in young patients with congenital adrenal hyperplasia, Bone, 18, 337, 10.1016/8756-3282(96)00003-8
Falhammar, 2007, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency, J Clin Endocrinol Metab, 92, 4643, 10.1210/jc.2007-0744
Ceccato, 2016, Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Eur J Endocrinol, 175, 101, 10.1530/EJE-16-0104
Chakhtoura, 2008, Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency, Eur J Endocrinol, 158, 879, 10.1530/EJE-07-0887
Barzon, 2003, Prevalence and natural history of adrenal incidentalomas, Eur J Endocrinol, 149, 273, 10.1530/eje.0.1490273
Kloos, 1995, Incidentally discovered adrenal masses, Endocr Rev, 16, 460
Jaresch, 1992, Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia, J Clin Endocrinol Metab, 74, 685
Barzon, 2007, The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience, J Endocrinol Invest, 30, 615, 10.1007/BF03346358
Varan, 2000, Adrenocortical carcinoma associated with adrenogenital syndrome in a child, Med Pediatr Oncol, 35, 88, 10.1002/1096-911X(200007)35:1<88::AID-MPO18>3.0.CO;2-I
Nermoen, 2011, High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency, Clin Endocrinol (Oxf), 75, 753, 10.1111/j.1365-2265.2011.04151.x
Völkl, 2009, Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Eur J Endocrinol, 160, 239, 10.1530/EJE-08-0770
Völkl, 2006, Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Pediatrics, 117, e98, 10.1542/peds.2005-1005
Cornean, 1998, Obesity in 21-hydroxylase deficient patients, Arch Dis Child, 78, 261, 10.1136/adc.78.3.261
Moyer, 2014, Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 160, 414, 10.7326/M13-2905
Lesma, 2014, Sexual function in adult life following Passerini-Glazel feminizing genitoplasty in patients with congenital adrenal hyperplasia, J Urol, 191, 206, 10.1016/j.juro.2013.07.097
Houben, 2014, Reconstructive surgery for females with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review from the Prince of Wales Hospital, Hong Kong Med J, 20, 481
Yankovic, 2013, Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey, J Pediatr Urol, 9, 1103, 10.1016/j.jpurol.2013.03.013
van der Zwan, 2013, Severity of virilization is associated with cosmetic appearance and sexual function in women with congenital adrenal hyperplasia: a cross-sectional study, J Sex Med, 10, 866, 10.1111/jsm.12028
Binet, 2016, Should we question early feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype, J Pediatr Surg, 51, 465, 10.1016/j.jpedsurg.2015.10.004
Crouch, 2008, Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia, J Urol, 179, 634, 10.1016/j.juro.2007.09.079
Nordenskjöld, 2008, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 93, 380, 10.1210/jc.2007-0556
Marei, 2016, Timing and outcome concerns regarding feminizing genitoplasty from the perspective of Egyptian families of girls with virilized external genitalia, Horm Res Paediatr, 85, 49, 10.1159/000442200
Martínez-Criado, 2013, [Role of pediatric urologist in the treatment of congenital adrenal hyperplasia: a study of satisfaction and psychosocial aspects], Cir Pediatr, 26, 75
Sturm, 2015, Congenital adrenal hyperplasia: current surgical management at academic medical centers in the United States, J Urol, 193, 1796, 10.1016/j.juro.2014.11.008
Roth, 2018, Characteristics of female genital restoration surgery for congenital adrenal hyperplasia using a large-scale administrative database, Urology, 115, 162, 10.1016/j.urology.2018.02.025
Sun, 2016, Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood, JAMA, 315, 2312, 10.1001/jama.2016.6967
Backeljauw, 2015, Cognition and brain structure following early childhood surgery with anesthesia, Pediatrics, 136, e1, 10.1542/peds.2014-3526
Merke, 2013, Management of adolescents with congenital adrenal hyperplasia, Lancet Diabetes Endocrinol, 1, 341, 10.1016/S2213-8587(13)70138-4
Szymanski, 2018, Parental decisional regret and views about optimal timing of female genital restoration surgery in congenital adrenal hyperplasia, J Pediatr Urol, 14, 156.e1, 10.1016/j.jpurol.2017.11.012
Auchus, 2010, Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia: guidance from the CARES Foundation initiative, Int J Pediatr Endocrinol, 2010, 275213, 10.1186/1687-9856-2010-275213
Peña, 1997, Total urogenital mobilization–an easier way to repair cloacas, J Pediatr Surg, 32, 263, 10.1016/S0022-3468(97)90191-3
Kalfa, 2008, 3-Dimensional neuroanatomy of the human fetal pelvis: anatomical support for partial urogenital mobilization in the treatment of urogenital sinus, J Urol, 180, 1709, 10.1016/j.juro.2008.03.089
Poppas, 2011, Clitoroplasty in congenital adrenal hyperplasia: description of technique, Adv Exp Med Biol, 707, 49, 10.1007/978-1-4419-8002-1_11
Peña, 1989, The surgical management of persistent cloaca: results in 54 patients treated with a posterior sagittal approach, J Pediatr Surg, 24, 590, 10.1016/S0022-3468(89)80514-7
Rink, 2005, Upper and lower urinary tract outcome after surgical repair of cloacal malformations: a three-decade experience, BJU Int, 96, 131, 10.1111/j.1464-410X.2005.05581.x
Rink, 2006, Use of the mobilized sinus with total urogenital mobilization, J Urol, 176, 2205, 10.1016/j.juro.2006.07.078
Stites, 2017, Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia, J Pediatr Urol, 13, 38.e1, 10.1016/j.jpurol.2016.10.012
Podesta, 2008, Perineal mobilization of the common urogenital sinus for surgical correction of high urethrovaginal confluence in patients with intersex disorders, J Pediatr Urol, 4, 352, 10.1016/j.jpurol.2008.02.009
Ludwikowski, 2013, The surgical correction of urogenital sinus in patients with DSD: 15 years after description of total urogenital mobilization in children, Front Pediatr, 1, 41, 10.3389/fped.2013.00041
Salle, 2012, Surgical treatment of high urogenital sinuses using the anterior sagittal transrectal approach: a useful strategy to optimize exposure and outcomes, J Urol, 187, 1024, 10.1016/j.juro.2011.10.162
Baskin, 1999, Anatomical studies of the human clitoris, J Urol, 162, 1015, 10.1016/S0022-5347(01)68052-2
Debono, 2009, Modified-release hydrocortisone to provide circadian cortisol profiles, J Clin Endocrinol Metab, 94, 1548, 10.1210/jc.2008-2380
Weitzman, 1971, Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects, J Clin Endocrinol Metab, 33, 14, 10.1210/jcem-33-1-14
Bryan, 2009, Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion, J Clin Endocrinol Metab, 94, 3477, 10.1210/jc.2009-0630
Merza, 2006, Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia, Clin Endocrinol (Oxf), 65, 45, 10.1111/j.1365-2265.2006.02544.x
Nella, 2016, A phase 2 study of continuous subcutaneous hydrocortisone infusion in adults with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 101, 4690, 10.1210/jc.2016-1916
Verma, 2010, A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia, Clin Endocrinol (Oxf), 72, 441, 10.1111/j.1365-2265.2009.03636.x
Mallappa, 2015, A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia, J Clin Endocrinol Metab, 100, 1137, 10.1210/jc.2014-3809
Neumann, 2018, Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency, Clin Endocrinol (Oxf), 88, 21, 10.1111/cen.13447
Laue, 1996, A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia, J Clin Endocrinol Metab, 81, 3535
Merke, 2000, Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 85, 1114, 10.1210/jcem.85.3.6462
Garrido, 2014, A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone, J Steroid Biochem Mol Biol, 143, 1, 10.1016/j.jsbmb.2014.01.013
de Bono, 2011, Abiraterone and increased survival in metastatic prostate cancer, N Engl J Med, 364, 1995, 10.1056/NEJMoa1014618
Ryan, 2013, Abiraterone in metastatic prostate cancer, N Engl J Med, 368, 1458
Auchus, 2014, Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency, J Clin Endocrinol Metab, 99, 2763, 10.1210/jc.2014-1258
New, 1989, Growth and final height in classical and nonclassical 21-hydroxylase deficiency, J Endocrinol Invest, 12, 91
Weintrob, 1997, Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height, Eur J Endocrinol, 136, 188, 10.1530/eje.0.1360188
Quintos, 2001, Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 86, 1511
Lin-Su, 2005, Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 90, 3318, 10.1210/jc.2004-2128
Dacou-Voutetakis, 1993, Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue, Ann N Y Acad Sci, 687, 250, 10.1111/j.1749-6632.1993.tb43873.x
Turcu, 2016, Single-dose study of a corticotropin-releasing factor receptor-1 antagonist in women with 21-hydroxylase deficiency, J Clin Endocrinol Metab, 101, 1174, 10.1210/jc.2015-3574
Bry-Gauillard, 2014, Mitotane for 21-hydroxylase deficiency in an infertile man, N Engl J Med, 371, 2042, 10.1056/NEJMc1410041
Cheng, 2016, ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo, Endocr Relat Cancer, 23, 1, 10.1530/ERC-15-0527
LaPensee, 2016, ATR-101, a selective and potent inhibitor of acyl-CoA acyltransferase 1, induces apoptosis in H295R adrenocortical cells and in the adrenal cortex of dogs, Endocrinology, 157, 1775, 10.1210/en.2015-2052
Sbiera, 2015, Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells, Endocrinology, 156, 3895, 10.1210/en.2015-1367
Van Wyk, 2003, The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia, J Clin Endocrinol Metab, 88, 2993, 10.1210/jc.2002-022026
Ogilvie, 2006, Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit’s experience, Eur J Endocrinol, 154, 405, 10.1530/eje.1.02096
Tiosano, 2010, Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy, Horm Res Paediatr, 74, 223, 10.1159/000295722
Crocker, 2012, Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia, J Clin Endocrinol Metab, 97, E2084, 10.1210/jc.2012-2298
Merke, 2000, Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency, N Engl J Med, 343, 1362, 10.1056/NEJM200011093431903
Riepe, 2006, Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Exp Clin Endocrinol Diabetes, 114, 105, 10.1055/s-2005-865836
Weise, 2004, Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise, J Clin Endocrinol Metab, 89, 591, 10.1210/jc.2003-030634
Green-Golan, 2007, Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise, J Clin Endocrinol Metab, 92, 3019, 10.1210/jc.2007-0493
Kim, 2014, Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia, J Clin Endocrinol Metab, 99, E1597, 10.1210/jc.2014-1274
Tajima, 1999, Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice, Gene Ther, 6, 1898, 10.1038/sj.gt.3301018
Ruiz-Babot, 2015, New directions for the treatment of adrenal insufficiency, Front Endocrinol (Lausanne), 6, 70, 10.3389/fendo.2015.00070
Ruiz-Babot, 2018, Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells, Cell Reports, 22, 1236, 10.1016/j.celrep.2018.01.003
Al-Maghribi, 2007, Congenital adrenal hyperplasia: problems with developmental anomalies of the external genitalia and sex assignment, Saudi J Kidney Dis Transpl, 18, 405
Chowdhury, 2015, Male gender identity in children with 46,XX DSD with congenital adrenal hyperplasia after delayed presentation in mid-childhood, J Pediatr Surg, 50, 2060, 10.1016/j.jpedsurg.2015.08.023
Meyer-Bahlburg, 2011, Gender monitoring and gender reassignment of children and adolescents with a somatic disorder of sex development, Child Adolesc Psychiatr Clin N Am, 20, 639, 10.1016/j.chc.2011.07.002
Lee, 2010, Should male gender assignment be considered in the markedly virilized patient With 46,XX and congenital adrenal hyperplasia, J Urol, 184, 1786, 10.1016/j.juro.2010.03.116
Meyer-Bahlburg, 2006, Gender development in women with congenital adrenal hyperplasia as a function of disorder severity, Arch Sex Behav, 35, 667, 10.1007/s10508-006-9068-9
Hines, 2015, Early androgen exposure and human gender development, Biol Sex Differ, 6, 3, 10.1186/s13293-015-0022-1
Meyer-Bahlburg, 2016, Gender assignment, reassignment and outcome in disorders of sex development: update of the 2005 consensus conference, Horm Res Paediatr, 85, 112, 10.1159/000442386
Hines, 2016, Prenatal androgen exposure alters girls’ responses to information indicating gender-appropriate behaviour, Philos Trans R Soc Lond B Biol Sci, 371, 20150125, 10.1098/rstb.2015.0125
Endendijk, 2016, Linking prenatal androgens to gender-related attitudes, identity, and activities: evidence from girls with congenital adrenal hyperplasia, Arch Sex Behav, 45, 1807, 10.1007/s10508-016-0693-7
Pasterski, 2015, Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4- to 11-year-old children, Arch Sex Behav, 44, 1363, 10.1007/s10508-014-0385-0
Dessens, 2005, Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia, Arch Sex Behav, 34, 389, 10.1007/s10508-005-4338-5
Meyer-Bahlburg, 2002, Gender assignment and reassignment in intersexuality: controversies, data, and guidelines for research, Adv Exp Med Biol, 511, 199, 10.1007/978-1-4615-0621-8_12
Liao, 2015, Parental choice on normalising cosmetic genital surgery, BMJ, h5124
Tamar-Mattis, 2014, Patient advocate responds to DSD surgery debate, J Pediatr Urol, 10, 788, 10.1016/j.jpurol.2014.03.019
Feder, 2016, Still ignoring human rights in intersex care, J Pediatr Urol, 12, 436, 10.1016/j.jpurol.2016.05.017
Dreger AD . Intersex and human rights: the long view. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:73–86.
Diamond M , BehH.G. The right to be wrong: sex and gender decisions. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:103–114.
Creighton SM . Adult outcomes of feminizing surgery. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:207–214.
Diamond, 1997, Management of intersexuality. Guidelines for dealing with persons with ambiguous genitalia, Arch Pediatr Adolesc Med, 151, 1046, 10.1001/archpedi.1997.02170470080015
Wisniewski, 2004, Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Urol, 171, 2497, 10.1097/01.ju.0000125269.91938.f7
Fagerholm, 2011, Sexual function and attitudes toward surgery after feminizing genitoplasty, J Urol, 185, 1900, 10.1016/j.juro.2010.12.099
Zhang, 2013, Long-term evaluation of patients undergoing genitoplasty due to disorders of sex development: results from a 14-year follow-up, Sci World J, 2013, 298015, 10.1155/2013/298015
Dayner JE , LeePA, HoukCP. Medical treatment of intersex: parental perspectives. J Urol. 2004;172(4 pt 2):1762–1765.
Lundberg, 2017, From knowing nothing to knowing what, how and now: parents’ experiences of caring for their children with congenital adrenal hyperplasia, J Pediatr Psychol, 42, 520
Reisch, 2011, Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency, Clin Endocrinol (Oxf), 74, 166, 10.1111/j.1365-2265.2010.03920.x
Frisén, 2009, Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency, J Clin Endocrinol Metab, 94, 3432, 10.1210/jc.2009-0636
Kuhnle, 1997, Outcome of congenital adrenal hyperplasia, Pediatr Surg Int, 12, 511, 10.1007/BF01258714
Kuhnle, 1995, The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life, Eur J Pediatr, 154, 708, 10.1007/BF02276713
Sanches, 2012, Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population, Int J Pediatr Endocrinol, 2012, 2, 10.1186/1687-9856-2012-2
Johannsen, 2006, Quality of life in 70 women with disorders of sex development, Eur J Endocrinol, 155, 877, 10.1530/eje.1.02294
Gilban, 2014, Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil, Health Qual Life Outcomes, 12, 107, 10.1186/s12955-014-0107-2
Strandqvist, 2014, Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden, J Clin Endocrinol Metab, 99, 1425, 10.1210/jc.2013-3326
Han, 2013, Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE), Eur J Endocrinol, 168, 887, 10.1530/EJE-13-0128
Engberg, 2015, Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study, Psychoneuroendocrinology, 60, 195, 10.1016/j.psyneuen.2015.06.017
Falhammar, 2014, Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 99, E554, 10.1210/jc.2013-3707
Clayton, 2002, Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society, Horm Res, 58, 188
Cohen-Kettenis P , PfafflinS. Transgenderism and Intersexuality in Childhood and Adolescence: Making Choices. Thousand Oaks, CA: Sage Publications; 2003.
Consortium on the Management of Disorders of Sex Development . Handbook for Parents. Available at: www.dsdguidelines.org. Accessed 14 September 2018.
Consortium on the Management of Disorders of Sex Development . Clinical Guidelines for the Management of Disorders of Sexual Differentiation in Childhood. Available at: www.dsdguidelines.org/. Accessed 14 September 2018.
Hughes, 2006, Consensus statement on management of intersex disorders, J Pediatr Urol, 2, 148, 10.1016/j.jpurol.2006.03.004
Brain, 2010, Holistic management of DSD, Best Pract Res Clin Endocrinol Metab, 24, 335, 10.1016/j.beem.2010.01.006
Martin, 2010, Patterns of gender development, Annu Rev Psychol, 61, 353, 10.1146/annurev.psych.093008.100511
Blakemore JE , BerenbaumSA, LibenLS. Gender Development. New York, NY: Psychology Press/Taylor & Francis Group; 2009.
Meyer-Bahlburg, 2017, Stigma in medical settings as reported retrospectively by women with congenital adrenal hyperplasia (CAH) for their childhood and adolescence, J Pediatr Psychol, 42, 496
Meyer-Bahlburg, 2008, Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess, Arch Sex Behav, 37, 85, 10.1007/s10508-007-9265-1
Meyer-Bahlburg, 2008, Treatment guidelines for children with disorders of sex development, Neuropsychiatr Enfance Adolesc, 56, 345, 10.1016/j.neurenf.2008.06.002
Money J. Sex Errors of the Body and Related Syndromes: A Guide to Counseling Children, Adolescents, and Their Families. 2nd ed. Baltimore, MD: Paul H. Brookes Publishing; 1994.
Hsu C , RivkeesSA. Congenital Adrenal Hyperplasia: A Parents’ Guide. Bloomington, IN: Author House; 2005.
Sandberg, 2017, Interdisciplinary care in disorders/differences of sex development (DSD): the psychosocial component of the DSD–Translational Research Network, Am J Med Genet C Semin Med Genet, 175, 279, 10.1002/ajmg.c.31561
Nordenström, 2014, Improving the communication of healthcare professionals with affected children and adolescents, Endocr Dev, 27, 113, 10.1159/000363636
McCauley, 2017, Challenges in educating patients and parents about differences in sex development, Am J Med Genet C Semin Med Genet, 175, 293, 10.1002/ajmg.c.31563
Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026
Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD